Make me your Homepage
    left corner left corner
    China Daily Website

    First TCM medicine OK'd for EU market

    Updated: 2012-04-19 07:43
    By Cheng Yingqi ( China Daily)

    A Chinese traditional medicine has been authorized for sale in a European market for the first time, the Chinese Academy of Sciences announced on Wednesday.

    Industry experts said the approval would lead the way for Chinese traditional medicine to enter the mainstream European market.

    First TCM medicine OK'd for EU market 

    Ninety-three-year-old Hu Yisong, a traditional Chinese medicine doctor, teaches a student from Pakistan how to distinguish TCM materials at a drugstore in Nantong, Jiangsu province, in March. You Lian / for China Daily 

    Di'ao Xin Xue Kang, a well-known herbal medicine produced by the Chengdu-based Di'ao Group, received marketing authorization from the Medicines Evaluation Board of the Netherlands, making it the first Chinese traditional drug to be identified as a therapeutic medicine in the European Union.

    "This is an important step for TCM to enter mainstream markets of developed countries," Health Minister Chen Zhu said at a news conference organized by the Chinese Academy of Sciences in Beijing on Wednesday.

    This first success was "proof that Chinese firms are capable of producing top-level medicines", he said.

    Bai Chunli, president of Chinese Academy of Sciences, urged TCM research institutions to increase their focus on the European market now.

    "As well as strengthening research, I hope they can also study the authorization requirements of different countries, so that more and more medicines will have access to the high-end market," he said.

    Sang Guowei, vice-chairman of the Standing Committee of the National People's Congress, said that TCM could finally enter European "rightfully".

    The certification of Di'ao Xin Xue Kang follows an EU ban on traditional Chinese medicine in May 2011, imposed to prevent unlicensed herbal medicines being sold as food supplements.

    "This new authorization marks the first time that Chinese traditional medicine steps into the mainstream health market," said Zhang Boli, a member of the Chinese Academy of Engineering and president of the China Academy of Chinese Medical Sciences.

    Zhang said another seven or eight Chinese TCM firms were trying to get access to the EU market.

    "Maybe one or two of them will receive authorization next year. And this may lead to more applicants, as the influence of TCM expands on international market," he added.

    Earlier reports said that the Guangzhou Qixing Pharmaceutical Company, the Foci Pharmaceutical Company in Lanzhou, and Tongrentang in Beijing are also striving for the EU market.

    "The medicine is also the first herbal medicine that has entered the EU market from a country outside the EU member states," said Li Bogang, president of the Di'ao Group.

    Li said the group took six years to obtain the certification from the Netherlands, although the medicine has been sold in China since 1988.

    The group carried out two years of research on active substances in TCM drugs with the help of the Netherlands Organization for Applied Scientific Research.

    "Without the help of the research organization, the application could have taken longer," Li said.

    "Di'ao Xin Xue Kang contains only a single portion of traditional medicine, which makes the research much easier than for a compound medicine, so we decided to use it in our first attempt at the EU market."

    Chen Keji, a member of the Chinese Academy of Sciences and chairman of the Chinese Association of Integrative Medicine, said identifying the active substances is essential when applying to enter the EU market.

    "In China, we currently do not have so strict requirements on the study of active substances, especially in compound medicines," Chen said. "For example, a TCM doctor may add or take out some herbs in prescriptions for different patients."

    "However, the healing principle is similar in TCM and Western medicine, so it's best we find out the effective parts in all medicines."

    Liu Jun, chief engineer of the research department of Guangzhou Qixing Pharmaceutical Company, said the basic research into active substances started in 2011, and will take at least another year to finish.

    "We are likely to promote our Xiaoyaowan and Biyanpian medicines next. Both are compound medicines," Liu said. "Compared with Di'ao Xin Xue Kang, the compound medicine is more complicated, so it takes time."

    8.03K
     
    ...
    Hot Topics
    Wei Guirong drives his granddaughters from kindergarten on his home-made three-wheeled vehicle in Luorong county, Liuzhou city of Guangxi Zhuang autonomous region, on May 19.
    ...
    ...
    人禽无码视频在线观看| 亚洲天堂中文资源| 成人精品一区二区三区中文字幕| 国内精品无码一区二区三区| 精品久久久久久无码中文字幕一区 | 一区二区三区无码高清| 亚洲Av综合色区无码专区桃色| 中文字幕高清有码在线中字| 播放亚洲男人永久无码天堂 | 少妇性饥渴无码A区免费| 亚洲av无码成人精品区| 人妻无码一区二区不卡无码av| 久久精品中文字幕第23页 | 中国少妇无码专区| 免费精品无码AV片在线观看| 亚洲一区精品无码| 最近中文字幕mv免费高清视频8| 亚洲AV无码一区二区一二区| 国产精品无码A∨精品影院| 亚洲av福利无码无一区二区| 免费无码作爱视频| 中文字幕精品无码久久久久久3D日动漫 | 岛国无码av不卡一区二区| 最近中文字幕完整版免费高清| 亚洲高清无码综合性爱视频| 国产仑乱无码内谢| 91精品国产综合久久四虎久久无码一级| 亚洲精品无码久久久影院相关影片| 免费无码又爽又刺激网站| 久久亚洲精品无码aⅴ大香| 中文字幕亚洲图片| 中文字幕无码人妻AAA片| 亚洲精品中文字幕无码蜜桃| 亚洲一区无码中文字幕| 亚洲色无码专区在线观看| 亚洲综合无码AV一区二区| 国产av无码专区亚洲av果冻传媒| 中文字幕无码毛片免费看| 成年无码av片完整版| 亚洲欧洲无码AV电影在线观看| 亚洲VA成无码人在线观看天堂 |